海创药业-U
(688302)
| 流通市值：21.32亿 | | | 总市值：29.02亿 |
| 流通股本：7272.45万 | | | 总股本：9901.56万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 109,734.51 | 109,734.51 | - | - |
| 营业收入 | 109,734.51 | 109,734.51 | - | - |
| 二、营业总成本 | 167,129,902.63 | 109,807,381.33 | 52,309,158.35 | 324,695,387.45 |
| 营业成本 | 96,520.22 | 96,520.22 | - | - |
| 税金及附加 | 335,459.57 | 231,720.29 | 95,256.11 | 417,127.34 |
| 销售费用 | 8,060,379.44 | 5,769,113.36 | 3,040,323.18 | 8,359,208.1 |
| 管理费用 | 31,408,401.17 | 21,367,152.41 | 10,022,409.53 | 79,641,804.34 |
| 研发费用 | 133,308,299.09 | 87,923,536.54 | 41,975,598.89 | 248,268,044.24 |
| 财务费用 | -6,079,156.86 | -5,580,661.49 | -2,824,429.36 | -11,990,796.57 |
| 其中:利息费用 | 386,144.54 | 267,493.09 | 145,706.48 | 1,487,704.66 |
| 其中:利息收入 | 7,707,333.76 | 5,528,478.01 | 2,983,287.64 | 12,139,204.31 |
| 加:公允价值变动收益 | 3,476,139.91 | 2,231,985.51 | 1,293,235.84 | 8,350,605.31 |
| 加:投资收益 | 6,944,387.25 | 5,071,737.14 | 3,003,684.53 | 16,482,692.49 |
| 信用减值损失(新) | -313,071.13 | -292,256.42 | -409,755.64 | -315,088.25 |
| 其他收益 | 2,852,236.87 | 2,284,727.81 | 1,208,194.75 | 6,042,899.23 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -154,060,475.22 | -100,401,452.78 | -47,213,798.87 | -294,134,278.67 |
| 加:营业外收入 | 1.75 | 1.43 | - | - |
| 减:营业外支出 | 2,072.96 | 1,713.38 | 1,028.54 | 5,049.2 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -154,062,546.43 | -100,403,164.73 | -47,214,827.41 | -294,139,327.87 |
| 减:所得税费用 | 8,886.5 | 8,881.38 | - | 19,086.27 |
| 六、净利润 | -154,071,432.93 | -100,412,046.11 | -47,214,827.41 | -294,158,414.14 |
| 持续经营净利润 | -154,071,432.93 | -100,412,046.11 | -47,214,827.41 | -294,158,414.14 |
| 归属于母公司股东的净利润 | -154,071,432.93 | -100,412,046.11 | -47,214,827.41 | -294,158,414.14 |
| (一)基本每股收益 | -1.56 | -1.01 | -0.48 | -2.97 |
| 八、其他综合收益 | -50,937.38 | 52,606.88 | 26,378.43 | -25,727.14 |
| 归属于母公司股东的其他综合收益 | -50,937.38 | 52,606.88 | 26,378.43 | -25,727.14 |
| 九、综合收益总额 | -154,122,370.31 | -100,359,439.23 | -47,188,448.98 | -294,184,141.28 |
| 归属于母公司股东的综合收益总额 | -154,122,370.31 | -100,359,439.23 | -47,188,448.98 | -294,184,141.28 |
| 公告日期 | 2024-10-26 | 2024-08-24 | 2024-04-27 | 2024-04-13 |
| 审计意见(境内) | | | | 标准无保留意见 |